Clinical Trial Update: A Phase I Study of BKM120 and Everolimus in Advanced Solid Malignancies [Phase 1]

View source ↗

Summary

Phase I study update on the combination of Buparlisib (BKM120) and Everolimus in patients with advanced solid tumors, including lung cancer, with the trial stat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Drugs mentioned

• Buparlisib (BKM120) (buparlisib)
• Everolimus (everolimus)

Snippet

Sponsor: Emory University | Conditions: Solid Tumors, Lung Cancer | Phase 1 | Status: COMPLETED